Skip to main content

Toxicology Transformed: From Opioids to Saliva - A Chemistry-Centric Journey

Tracking # 20-1316692

Free

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Prerecorded Broadcast

Course overview

As drug trends and diagnostic technologies evolve, toxicology must adapt to meet the demands of healthcare, workplace safety, and public health - focusing on opioid detection, CBD use, patient-centered testing, and new methods like saliva analysis, each bringing distinct challenges and opportunities. The following podcast episodes feature chemistry-related interviews that discuss these topics. Objectives: 1. Differentiate between opiates and opioids, and accurately classify controlled substances within these categories to support appropriate clinical and public health responses. 2. Identify Delta-9-tetrahydrocannabinol (THC) as the main psychoactive component of marijuana, and describe its physiological effects. 3. Recognize the legal minimum threshold of Delta-9 THC in cannabis products and describe the advanced analytical methods.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General (Clinical Chemistry/UA/Toxicology)

Clinical Laboratory Supervisor

1h General (Clinical Chemistry/UA/Toxicology)

Clinical Laboratory Technician

1h General (Clinical Chemistry/UA/Toxicology)

Clinical Laboratory Technologist

1h General (Clinical Chemistry/UA/Toxicology)

Public Health Director

1h General (Clinical Chemistry/UA/Toxicology)

Public Health Supervisor

1h General (Clinical Chemistry/UA/Toxicology)

Public Health Technologist

1h General (Clinical Chemistry/UA/Toxicology)

Disclosure statements